Sarepta Therapeutics Inc
Change company Symbol lookup
Select an option...
SRPT Sarepta Therapeutics Inc
VGI Virtus Global Multi-Sector Income Fund
VDE Vanguard Energy Index Fund ETF Shares
VCV Invesco California Value Municipal Income Trust
VCSH Vanguard Short-Term Corporate Bond Index Fund ETF Shares
VBR Vanguard Small-Cap Value Index Fund ETF Shares
V Visa Inc
UPS United Parcel Service Inc
UNM Unum Group
UNH UnitedHealth Group Inc
Go

Health Care : Biotechnology | Mid Cap Growth
Company profile

Sarepta Therapeutics, Inc. is a biopharmaceutical company. The Company focuses on the discovery and development of ribose nucleic acid (RNA)-targeted therapeutics for the treatment of rare neuromuscular diseases. It operates through discovering, developing, manufacturing and delivering therapies to patients with Duchenne muscular dystrophy (DMD). It is focused on the development of its disease-modifying DMD drug candidates. It has received accelerated approval for its product, EXONDYS 51, indicated for the treatment of DMD in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping. EXONDYS 51 is studied in clinical trials under the name of eteplirsen. Its next generation phosphorodiamidate morpholino oligomer (PMO)-based compounds are synthetic compounds that bind to complementary sequences of RNA by standard Watson-Crick nucleobase pairing. Its PMO-based chemistries are peptide conjugated PMO (PPMO), PMO-X and PMOplus.

Closing Price
$165.68
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
1,070,592
0
  • Prev Close
    165.68
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    1.1M
  • Last (time)
    4:00p ET 07/01/20
  • Last (size)
    15
  • 52-Wk Range
    72.05 - 172.70
    LowHigh
  • (09/26/19 - 06/23/20)
    4.06%
  • 59.9%
  • Market Cap
    12.9B
  • Shares Outstanding
    78.0M
  • -8.83
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.9
  • 93.20
  • (% of float 06/15/20)
    16.75

Latest News

June 30, 2020
6:15 pm ET
Globe Newswire
8:30 am ET
Globe Newswire
June 26, 2020
8:30 am ET
Globe Newswire
June 22, 2020
8:00 am ET
Globe Newswire
June 18, 2020
8:30 am ET
Globe Newswire
8:30 am ET
Globe Newswire
June 15, 2020
11:00 am ET
Globe Newswire
June 08, 2020
8:55 am ET
Globe Newswire
June 05, 2020
4:05 pm ET
Globe Newswire
June 02, 2020
5:00 pm ET
Globe Newswire
8:00 am ET
BusinessWire
May 29, 2020
6:28 pm ET
Globe Newswire
May 12, 2020
4:35 pm ET
Globe Newswire
May 11, 2020
7:00 am ET
Globe Newswire
May 06, 2020
4:27 pm ET
Globe Newswire
April 30, 2020
6:52 pm ET
Globe Newswire
April 29, 2020
8:30 am ET
Globe Newswire
April 28, 2020
8:30 am ET
Globe Newswire
April 27, 2020
12:03 pm ET
BusinessWire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.